Action Ramm Pharma - RAMM

Ramm Pharma Corp (RAMM) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

0,015

( - )

Prix Achat

0,01

Prix Vente

0,015

Volume échangé

0,00 Fourchette du Jour 0,00

0,01 Plage de 52 semaines 0,25

Cap du marché

1,791M

Clôture Veille

0,015

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

$ 87 594

Actions en circulation

119 389 317

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-0,21

Bénéfice par action (BPA)

-0,07

Chiffre d'affairess (LTM)

2,56M

Bénéfice net (LTM)

-8,65M

RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmeti... RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products. It also engages in the resale of medical supplies products; and the sale of medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada. Show more

Secteur

Healthcare

Industrie

Pharmaceuticals

Site Web

www.wearerammpharma.com

Siège social

Toronto, Canada

Fondé

1987

Ramm Pharma Corp est coté dans le secteur Healthcare de la Canadian Securities Exchange avec le ticker RAMM. Le dernier cours de clôture d'Ramm Pharma était de $0,02. Au cours de la dernière année, les actions de Ramm Pharma ont été négociées dans une fourchette de prix de $ 0,01 à $ 0,25.

Ramm Pharma compte actuellement 119 389 317 actions en circulation. La capitalisation boursière d'Ramm Pharma est de $1,79 million. Ramm Pharma a un ratio cours/bénéfice (ratio PE) de -0.21.

RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders

TORONTO, Nov. 07, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials

TORONTO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Commences Epifractán™ Sales through Peruvian Pharmacies and Scales up Exports to Brazil

TORONTO, Oct. 08, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Announces Approval and Registration of Epifractán™ 2% by Peru’s Ministry of Health

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Announces Approval and Registration of Epifractán™ 5% by Peru’s Ministry of Health and Enters Distribution A...

TORONTO, July 09, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.015	0.015	0.01	12400	0.015	CS
4	0.005	50	0.01	0.015	0.01	6757	0.01497192	CS
12	0	0	0.015	0.02	0.01	17913	0.01416324	CS
26	-0.035	-70	0.05	0.06	0.01	24782	0.02497886	CS
52	0.005	50	0.01	0.25	0.01	35083	0.04064625	CS
156	-0.045	-75	0.06	0.25	0.005	40876	0.04017973	CS
260	-0.835	-98.2352941176	0.85	0.85	0.005	65275	0.16863889	CS

RAMM - Frequently Asked Questions (FAQ)

What is the current Ramm Pharma Corp share price?

The current share price of Ramm Pharma Corp is $ 0,015

How many Ramm Pharma Corp shares are in issue?

Ramm Pharma Corp has 119 389 317 shares in issue

What is the market cap of Ramm Pharma Corp?

The market capitalisation of Ramm Pharma Corp is CAD 1,79M

What is the 1 year trading range for Ramm Pharma Corp share price?

Ramm Pharma Corp has traded in the range of $ 0,01 to $ 0,25 during the past year

What is the PE ratio of Ramm Pharma Corp?

The price to earnings ratio of Ramm Pharma Corp is -0,21

What is the cash to sales ratio of Ramm Pharma Corp?

The cash to sales ratio of Ramm Pharma Corp is 0,7

What is the registered address of Ramm Pharma Corp?

The registered address for Ramm Pharma Corp is 200, 82 Richmond St. East, Toronto, Ontario, M5C 1P1

What is the Ramm Pharma Corp website address?

The website address for Ramm Pharma Corp is www.wearerammpharma.com

Which industry sector does Ramm Pharma Corp operate in?

Ramm Pharma Corp operates in the Pharmaceuticals sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ramm Pharma Corp (RAMM)

Ramm Pharma Corp (RAMM) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Ramm Pharma Corp

RAMM Dernières nouvelles

RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.

RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders

RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials

RAMM Pharma Commences Epifractán™ Sales through Peruvian Pharmacies and Scales up Exports to Brazil

RAMM Pharma Announces Approval and Registration of Epifractán™ 2% by Peru’s Ministry of Health

RAMM Pharma Announces Approval and Registration of Epifractán™ 5% by Peru’s Ministry of Health and Enters Distribution A...

RAMM Pharma announces its quarter financial results for Q2 2020

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements

RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution

RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.

RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders

RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials

RAMM - Frequently Asked Questions (FAQ)

RAMM Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ramm Pharma Corp (RAMM)

Ramm Pharma Corp (RAMM) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Ramm Pharma Corp

RAMM Dernières nouvelles

RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.

RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders

RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials

RAMM Pharma Commences Epifractán™ Sales through Peruvian Pharmacies and Scales up Exports to Brazil

RAMM Pharma Announces Approval and Registration of Epifractán™ 2% by Peru’s Ministry of Health

RAMM Pharma Announces Approval and Registration of Epifractán™ 5% by Peru’s Ministry of Health and Enters Distribution A...

RAMM Pharma announces its quarter financial results for Q2 2020

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements

RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution

RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.

RAMM Pharma Corp. Provides Additional Disclosure in Connection with its Upcoming Special Meeting of Shareholders

RAMM Pharma Corp. Provides Update on Canada post strike and mailing of the Company´s meeting materials

RAMM - Frequently Asked Questions (FAQ)

RAMM Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités